1. Home
  2. COCO vs BEAM Comparison

COCO vs BEAM Comparison

Compare COCO & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Vita Coco Company Inc.

COCO

The Vita Coco Company Inc.

HOLD

Current Price

$76.29

Market Cap

3.0B

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$29.23

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COCO
BEAM
Founded
2004
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.0B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
COCO
BEAM
Price
$76.29
$29.23
Analyst Decision
Buy
Buy
Analyst Count
9
12
Target Price
$57.75
$50.75
AVG Volume (30 Days)
1.6M
1.8M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
26.60
82.31
EPS
0.50
N/A
Revenue
N/A
$24,000.00
Revenue This Year
$16.12
N/A
Revenue Next Year
$11.40
$33.77
P/E Ratio
$151.99
N/A
Revenue Growth
N/A
33.33
52 Week Low
$31.82
$15.60
52 Week High
$79.99
$36.44

Technical Indicators

Market Signals
Indicator
COCO
BEAM
Relative Strength Index (RSI) 67.16 51.34
Support Level $50.99 $27.89
Resistance Level $79.99 $32.01
Average True Range (ATR) 2.73 1.81
MACD -0.16 -0.33
Stochastic Oscillator 68.57 40.92

Price Performance

Historical Comparison
COCO
BEAM

About COCO The Vita Coco Company Inc.

The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: